PT80214B - Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon - Google Patents

Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon

Info

Publication number
PT80214B
PT80214B PT80214A PT8021485A PT80214B PT 80214 B PT80214 B PT 80214B PT 80214 A PT80214 A PT 80214A PT 8021485 A PT8021485 A PT 8021485A PT 80214 B PT80214 B PT 80214B
Authority
PT
Portugal
Prior art keywords
rectum
colon
dione
dichloro
methyl
Prior art date
Application number
PT80214A
Other languages
English (en)
Other versions
PT80214A (en
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of PT80214A publication Critical patent/PT80214A/pt
Publication of PT80214B publication Critical patent/PT80214B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
PT80214A 1984-04-03 1985-04-02 Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon PT80214B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8405222A FR2561919B1 (fr) 1984-04-03 1984-04-03 Composition pharmaceutique constituee d'une part, a titre de principe actif, par la 9a,11b-dichloro 16a-methyl 21-oxycarbonyldicyclohexyl methyloxy pregna-1,4-diene 3,20-dione et d'autre part, par un excipient pharmaceutique inerte apte a permettre l'action du produit dans le rectum ou le colon

Publications (2)

Publication Number Publication Date
PT80214A PT80214A (en) 1985-05-01
PT80214B true PT80214B (en) 1987-02-17

Family

ID=9302777

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80214A PT80214B (en) 1984-04-03 1985-04-02 Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon

Country Status (16)

Country Link
US (1) US4614736A (pt)
EP (1) EP0161144B1 (pt)
JP (1) JPS60224615A (pt)
AT (1) ATE41604T1 (pt)
AU (1) AU571073B2 (pt)
CA (1) CA1226817A (pt)
DE (1) DE3568944D1 (pt)
DK (1) DK164478C (pt)
FR (1) FR2561919B1 (pt)
GR (1) GR850815B (pt)
HU (1) HU196122B (pt)
IL (1) IL74642A (pt)
MA (1) MA20388A1 (pt)
OA (1) OA07978A (pt)
PT (1) PT80214B (pt)
ZA (1) ZA851927B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8909559D0 (en) * 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
US5578576A (en) * 1994-09-02 1996-11-26 Dalhousie University Method and composition for treating intestinal wounds or ulcers
US20050059583A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US7151085B2 (en) * 2004-11-15 2006-12-19 Allergan, Inc. Therapeutic methods using cyclosporine components
US7135455B2 (en) * 2004-11-15 2006-11-14 Allergan, Inc Methods for the therapeutic use of cyclosporine components

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
FR2561919A1 (fr) 1985-10-04
AU4080085A (en) 1985-10-10
DK164478C (da) 1992-11-23
US4614736A (en) 1986-09-30
HUT44436A (en) 1988-03-28
DK146785A (da) 1985-10-04
FR2561919B1 (fr) 1986-12-19
MA20388A1 (fr) 1985-10-01
ATE41604T1 (de) 1989-04-15
OA07978A (fr) 1987-01-31
IL74642A (en) 1988-09-30
DE3568944D1 (en) 1989-04-27
PT80214A (en) 1985-05-01
ZA851927B (en) 1986-04-30
CA1226817A (fr) 1987-09-15
GR850815B (pt) 1985-07-23
IL74642A0 (en) 1985-06-30
DK164478B (da) 1992-07-06
EP0161144B1 (fr) 1989-03-22
AU571073B2 (en) 1988-03-31
HU196122B (en) 1988-10-28
DK146785D0 (da) 1985-04-01
EP0161144A1 (fr) 1985-11-13
JPS60224615A (ja) 1985-11-09

Similar Documents

Publication Publication Date Title
EP0147261A3 (en) Medicine and medicinal composition for the treatment and the prevention of skin affections involving an inflammation process
DE2962122D1 (en) 17-alkylcarbonates of corticoids, process for their preparation and their use as medicines against dermatoses
HUT37781A (en) Process for producing 1-fluorphenyl-butyl-4-/2-pirimidinyl/-piperazine derivatives and pharmaceutical compositions containing them as active agents
PT76314B (en) Process for the preparation of biologically active polysaccharide concentrates and of pharmaceutical and cosmetic compositions containing them
EP0137543A3 (en) Pharmaceutical composition for the therapy of peripheral arteriopathies
DE3062981D1 (en) Alkyl-urea derivatives for the treatment of lipometabolic diseases; process for their preparation, their use in medicaments for the treatment of lipometabolic disorders, medicaments containing them, process for the preparation of the medicaments, and some alkyl-urea derivatives
IE802589L (en) Anti-inflammatory pharmaceutical composition containing¹rosmarinic acid
DE2964774D1 (en) 2,6-dialkoxybenzamides, process for their preparation, compositions and these compounds for use in the treatment of psychotic disordes
PT76247B (en) Process for preparing antiinflammatory and/or analgesic 2,3-diaryl-5-halo thiophenes and of pharmaceutical compositions containing the same
ZA796918B (en) Pharmaceutical composition for treating neoplastic diseases and methods of preparation
PT80214A (en) Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon
DE2962580D1 (en) 7-phenyl-quinolizidine derivatives (i), their preparation, pharmaceutical compositions containing them and (i) for use in treating diseases
ZA784083B (en) Fatty acid and derivatives thereof,and formulations containing them for use in treatment or prophyllaxis of thrombo-embolic conditions
HUT39437A (en) Process for producing new morpholinol derivatives and pharmaceutical compositions containing them as active agents
DE2963141D1 (en) New compounds related to dilignols, compounds related to dilignols for use in the treatment of liver deseases and pharmaceutical compositions containing them
ZA857721B (en) Process for treatment of rheumatic diseases
GB2030043B (en) Injectable composition for the treatment of helminthiasis and clostridial diseases in animals
EP0158880A3 (en) Liposomes with inhalable allergens for treatment of allergies, method for their preparation and pharmaceutical compositions containing them
ES8401929A1 (es) Procedimiento de preparar derivados de p-acilaminofenol.
HUT37785A (en) Process for producing 3-alkoxy-2-pyrrolidino-n-pyrimidinyl-or -n-pyrazinyl-propyl-amines and pharmaceutical compositions containing them as active agents
HUT44073A (en) Process for producing purified human angiogene factor and pharmaceutical compositions containing them
HUT34445A (en) Process for producing 1-phenoxy-3-/hydroxy-indolyl-alkyl-amino/-"aepropanoles and pharmaceutical compositions containing them as active ingredients
PT94787A (pt) Processo de preparacao de composicoes farmaceuticas para administracao transdermica de corticosteroides e de compostos com actividade fisiologica semelhante
AU514653B2 (en) Pharmaceutical preparations forthe treatment of disorders in calcium metabolism
ES8307810A1 (es) "procedimiento para la preparacion de nuevos 2-metilen-lh-2,3,5,6-tetrahidro-imidazoni,2-a imidazoles".

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19920830